Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Narvaez

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Lupus Science & Medicine|January 27, 2026
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN RegistryPaola Vidal-Montal, Aina Fabregat, Irene Altabás-González, et al.
Plos One|May 8, 2018
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritisRosario Lopez-Rodriguez, Eva Perez-Pampin, Ana Marquez, et al.
International Journal of Molecular Sciences|September 9, 2023
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?Joao Carlos Batista-Liz, Vanesa Calvo-Río, María Sebastián Mora-Gil, et al.
Plos One|March 1, 2019
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanerceptAida Ferreiro-Iglesias, Ariana Montes, Eva Perez-Pampin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2014
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patientsFrancisco Ortiz-Sanjuán, Ricardo Blanco, Vanesa Calvo-Rio, et al.
Frontiers in Immunology|November 10, 2025
The role of <i>NFKB1</i> and <i>NFKBIA</i> in immunoglobulin A vasculitisJoao Carlos Batista-Liz, María Sebastián Mora-Gil, Mónica Renuncio García, et al.
Arthritis Research & Therapy|March 12, 2014
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisAna Márquez, Aida Ferreiro-Iglesias, Cristina L Dávila-Fajardo, et al.
Scientific Reports|November 20, 2021
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndromeSara Remuzgo-Martínez, Belén Atienza-Mateo, J Gonzalo Ocejo-Vinyals, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2026
Accelerating real-world prediction and research in Alzheimer's: The M3AD studyMoïse Desvarieux, Tatjana Rundek, Habibul Ahsan, et al.
Rheumatology International|August 6, 2025
High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort studyOlga Rusinovich-Lovgach, Zulema Plaza, Mónica Fernández-Castro, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Lupus Science & Medicine|January 27, 2026
Real-world experience with belimumab-based triple therapy in proliferative lupus nephritis: data from the BEL-SPAIN RegistryPaola Vidal-Montal, Aina Fabregat, Irene Altabás-González, et al.
Plos One|May 8, 2018
Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritisRosario Lopez-Rodriguez, Eva Perez-Pampin, Ana Marquez, et al.
International Journal of Molecular Sciences|September 9, 2023
Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?Joao Carlos Batista-Liz, Vanesa Calvo-Río, María Sebastián Mora-Gil, et al.
Plos One|March 1, 2019
Evaluation of 12 GWAS-drawn SNPs as biomarkers of rheumatoid arthritis response to TNF inhibitors. A potential SNP association with response to etanerceptAida Ferreiro-Iglesias, Ariana Montes, Eva Perez-Pampin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2014
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patientsFrancisco Ortiz-Sanjuán, Ricardo Blanco, Vanesa Calvo-Rio, et al.
Frontiers in Immunology|November 10, 2025
The role of <i>NFKB1</i> and <i>NFKBIA</i> in immunoglobulin A vasculitisJoao Carlos Batista-Liz, María Sebastián Mora-Gil, Mónica Renuncio García, et al.
Arthritis Research & Therapy|March 12, 2014
Lack of validation of genetic variants associated with anti-tumor necrosis factor therapy response in rheumatoid arthritis: a genome-wide association study replication and meta-analysisAna Márquez, Aida Ferreiro-Iglesias, Cristina L Dávila-Fajardo, et al.
Scientific Reports|November 20, 2021
Role of MUC1 rs4072037 polymorphism and serum KL-6 levels in patients with antisynthetase syndromeSara Remuzgo-Martínez, Belén Atienza-Mateo, J Gonzalo Ocejo-Vinyals, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 18, 2026
Accelerating real-world prediction and research in Alzheimer's: The M3AD studyMoïse Desvarieux, Tatjana Rundek, Habibul Ahsan, et al.
Rheumatology International|August 6, 2025
High incidence of lymphoma in Sjögren's disease: predictors and mortality implications in a prospective cohort studyOlga Rusinovich-Lovgach, Zulema Plaza, Mónica Fernández-Castro, et al.
Pageof 6